Pharmaceuticals

Hisun Pharma, founded in 1956, now is the one of the leading pharmaceutical manufactures in China. We are inspected by USFDA, EDQM, HPFB, TGA, APVMA, DCGI, etc.. We have broad portfolio of APIs including Oncology, Cardiovascular, Anti-infectives，Anti-parasitic, etc.

NORTH CHINA PHARMACEUTICAL GROUP SEMISYNTECH CO., LTD is a wholly-owned subsidiary of NCPC, which is specialized in manufacturing and sales of penicillin series products including pharmaceutical intermediates and APIs. The company is located in economic & technical development zone of Liangcun, Shijiazhuang.

Shandong Shengli Bioengineering Co., Ltd is a joint venture built by China Animal Husbandry Industry Co., Ltd and Shandong Shengli Co., Ltd. We are national high-tech enterprise, and mainly producing animal-specific antibiotic API, veterinary preparations and feed additives, such as Tiamulin Fumarate, Enramycin, Bambermycin, Nosiheptide, and Monensin, etc. Shengli strictly follows the current GMP regulations in Europe and the United States, establishes a sound quality management system, and has passed ISO9001, ISO14001, ISO45001 certification, and the US FDA site audit with "0-483". Tiamulin Fumarate API is the first to obtain the EU COS Certificate in China, Enramycin is the first to obtain Production and Sale Certificate domestically. Based in China, with a global business strategy, the company has built a global marketing network.

Chengda Pharmaceuticals Co., LTD. was set up in 1999, located in the beautiful scenery of the Hangzhou-Jiaxing-Huzhou plain. Our company mainly produces APIs, food addictives, feed addictives, antibiotics, anticancer, antiviral of pharmaceutical intermediates, and etc,  sold in more than 30 countries and regions.  We are the largest Asian bulk pharmaceutical enterprises specializing in producing and exporting Carnitine range.  Our facilities have passed the US FDA on-site inspection.